Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,674 INR | +0.99% | +1.59% | +3.74% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
Sales 2024 | 22.27B 268M | Sales 2025 * | 24.98B 301M | Capitalization | 222B 2.67B |
---|---|---|---|---|---|
Net income 2024 | 3.58B 43.06M | Net income 2025 * | 4.18B 50.27M | EV / Sales 2024 | 8.44 x |
Net cash position 2024 * | 7.68B 92.46M | Net cash position 2025 * | 10.03B 121M | EV / Sales 2025 * | 8.49 x |
P/E ratio 2024 |
52.6
x | P/E ratio 2025 * |
53.5
x | Employees | 4,048 |
Yield 2024 * |
0.63% | Yield 2025 * |
0.82% | Free-Float | 43.38% |
Latest transcript on Dr. Lal PathLabs Limited
1 day | +0.99% | ||
1 week | +1.59% | ||
Current month | +0.99% | ||
1 month | +15.34% | ||
3 months | +14.58% | ||
6 months | -2.51% | ||
Current year | +3.74% |
Managers | Title | Age | Since |
---|---|---|---|
Shankha Banerjee
CEO | Chief Executive Officer | - | 14-06-30 |
Ved Prakash Goel
DFI | Director of Finance/CFO | - | 05-12-31 |
Arvind Lal
CHM | Chairman | 74 | 95-02-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 58 | 23-07-26 | |
Director/Board Member | 77 | 15-08-20 | |
Arvind Lal
CHM | Chairman | 74 | 95-02-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 6 M€ | +6.07% | - | |
0.01% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +4.57% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 2,674 | +0.99% | 127,311 |
24-05-31 | 2,648 | +0.78% | 215,608 |
24-05-30 | 2,627 | -1.01% | 151,205 |
24-05-29 | 2,654 | +1.41% | 166,094 |
24-05-28 | 2,617 | -0.58% | 105,942 |
Delayed Quote NSE India S.E., June 03, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.74% | 2.63B | |
-25.58% | 7.76B | |
+69.31% | 4.33B | |
-3.33% | 2.64B | |
-47.63% | 2.16B | |
-16.44% | 1.75B | |
-19.40% | 1.46B | |
+14.52% | 1.17B | |
-45.53% | 1.14B | |
+19.68% | 999M |
- Stock Market
- Equities
- LALPATHLAB Stock